Predictors of mortality at 1 year post-TAVI in patients with a logEuroSCORE <20%
Univariate OR (95% CI) | P value | Multivariate OR (95% CI)* | P value | |
Age (years) | 1.001 (0.965 to 1.038) | 0.947 | 0.996 (0.950 to 1.044) | 0.868 |
Female gender | 1.176 (0.726 to 1.905) | 0.509 | 1.482 (0.842 to 2.609) | 0.172 |
Cardiac history | ||||
Prior MI | 1.028 (0.488 to 2.165) | 0.942 | 0.854 (0.360 to 2.024) | 0.720 |
Prior cardiac surgery† | 0.802 (0.397 to 1.620) | 0.539 | 0.772 (0.337 to 1.771) | 0.542 |
Prior stroke | 0.814 (0.312 to 2.123) | 0.674 | 0.745 (0.248 to 2.236) | 0.600 |
Comorbidities | ||||
AF | 1.716 (1.065 to 2.766) | 0.027 | 1.620 (0.947 to 2.770) | 0.078 |
Hypertension | 1.991 (0.601 to 6.595) | 0.260 | 1.360 (0.389 to 4.761) | 0.630 |
CAD | 1.815 (1.112 to 2.961) | 0.017 | 2.408 (1.361 to 4.262) | 0.003 |
Mitral valve insufficiency (>II°) | 1.757 (0.485 to 6.367) | 0.391 | 1.636 (0.403 to 6.638) | 0.491 |
Porcelain aorta | 1.263 (0.752 to 2.121) | 0.377 | 1.115 (0.638 to 1.950) | 0.702 |
Pulmonary hypertension | 1.628 (0.905 to 2.928) | 0.104 | 1.527 (0.797 to 2.926) | 0.202 |
COPD | 1.169 (0.648 to 2.110) | 0.605 | 1.154 (0.605 to 2.202) | 0.664 |
Diabetes mellitus | 1.166 (0.692 to 1.964) | 0.564 | 0.966 (0.539 to 1.733) | 0.908 |
Kidney insufficiency | 1.156 (0.721 to 1.854) | 0.546 | 0.983 (0.580 to 1.667) | 0.949 |
NYHA class III or IV | 1.716 (0.853 to 3.453) | 0.130 | 1.519 (0.732 to 3.152) | 0.262 |
LVEF (%) | 0.990 (0.969 to 1.011) | 0.346 | 0.988 (0.964 to 1.013) | 0.352 |
Peak AV gradient (mm Hg) | 1.002 (0.992 to 1.012) | 0.747 | 0.999 (0.978 to 1.021) | 0.931 |
Mean AV gradient (mm Hg) | 1.003 (0.988 to 1.018) | 0.668 | 1.012 (0.981 to 1.045) | 0.446 |
*Adjusted for all other variables.
†Not including percutaneous coronary intervention.
AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; TA, transapical; TF, transfemoral.